PET scan study for new pancreatic and head and neck cancers
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial uses a special PET scan tracer to see how it spreads in the body for people newly diagnosed with pancreatic or head and neck cancer who haven't had treatment yet. It aims to help doctors better understand and potentially treat these cancers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have been newly diagnosed with pancreatic cancer or head and neck cancer (confirmed by biopsy).
- You cannot have had any surgery, radiation, or chemotherapy for this cancer yet.
- You must be willing and able to have a PET/CT scan.
- You cannot have severe liver or kidney problems, or be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET scan (68Ga-grazytracer) to see how well immunotherapy is working for pancreatic cancer. It may help your doctor understand if your treatment is effective.
This study tests a new type of imaging scan (PET/CT or PET/MR) that uses a radioactive tracer to help doctors better detect and diagnose various cancers. The scan targets a specific protein found in tumors, which may help identify cancer more accurately than standard imaging.
This study uses a special PET scan drug (Ga-FAPI-46) to create clearer pictures of pancreatic and bile duct cancers. It may help doctors decide on the best next steps—especially before surgery—by checking tumor size and looking for spread.
This study tests a new type of PET scan (a detailed imaging test) called [68Ga]Ga-FAPI that may help doctors see cancer better and faster than standard scans. You'll receive this experimental scan to see if it improves cancer detection before surgery.
This trial tests a new type of PET scan that uses a special tracer (FAPI) to get clearer images of pancreatic cancer. The goal is to find cancer earlier and better plan surgery or treatment.
This study tests a new type of PET scan that uses a radioactive tracer called FAPI-74 to find cancer spread in people with pancreatic cancer. The goal is to see if this scan can help doctors better plan treatment.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.